Retrospective evaluation of pregnancy outcomes in women with familial Mediterranean fever

References

• Eliakim M, Levy M, Ehrenfeld M. Recurrent polyserositis (familial Mediterranean fever, periodic disease). New York: Elsevier/North-Holland; 1981:5–14
   Google Scholar
• Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998;351:659–64
   PubMed Web of Science ®Google Scholar
• Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine 2005;84:1–11
   PubMed Web of Science ®Google Scholar
• Cobankara V, Fidan G, Turk T, et al. The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 2004;22:S27–30
   PubMed Web of Science ®Google Scholar
• Samuels J, Aksentijevich I, Torosyan Y, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the national institutes of health. Medicine 1998;77:268–97
   PubMed Web of Science ®Google Scholar
• Mor A, Gal R, Livneh A. Abdominal and digestive system associations of familial Mediterranean fever. Am J Gastroenterol 2003;98:2594–604
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis 2003;62:916–9
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Levy M. Colchicine update 1998 Semin Arthritis Rheum 1998;28:48–59
   Google Scholar
• Zemer D, Pras M, Sohar E, et al. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001–3
   PubMed Web of Science ®Google Scholar
• Matzner Y. Biologic and clinical advances in familial Mediterranean fever. Crit Rev Oncol Hematol 1995;18:197–205
   Google Scholar
• Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997;40:1879–85
   PubMed Web of Science ®Google Scholar
• Ofir D, Levy A, Wiznitzer A, et al. Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery. Eur J Obstet Gynecol Reprod Biol 2008;141:115–8
   PubMed Web of Science ®Google Scholar
• Tunca M, Tankurt E. The efficacy of interferon alpha on colchicine resistant FMF attacks. Br J Rheumatol 1997;36:1005–8
   PubMedGoogle Scholar
• Diav-Citrin O, Shechtman S, Schwartz V, et al. Pregnancy outcome after in utero exposure to colchicine. Am J Obstet Gynecol 2010;203:144.e1–6
   PubMed Web of Science ®Google Scholar
• Ben-Chetrit E, Ben-Chetrit A, Berkun Y, Ben-Chetrit E. Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified? Arthritis Care Res 2010;62:143–8
   Web of Science ®Google Scholar
• Gomez R, Romero R, Edwin SS, David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection. Infect Dis Clin North Am 1997;11:135–76
   PubMed Web of Science ®Google Scholar
• Fortunato SJ, Menon R, Lombardi SJ. Support for an infection-induced apoptotic pathway in human fetal membranes. Am J Obstet Gynecol 2001;184:1392–7
   PubMed Web of Science ®Google Scholar
• Romero R, Friel LA, Velez Edwards DR, et al. A genetic association study of maternal and fetal candidate genes that predispose to preterm prelabor rupture of membranes (PROM). Am J Obstet Gynecol 2010;203:361
   Google Scholar
• Ferrand PE, Parry S, Sammel M, et al. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African Americans. Mol Hum Reprod 2002;8:494–501
   PubMed Web of Science ®Google Scholar
• Fujimoto T, Parry S, Urbanek M, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes. J Biol Chem 2002;277:6296–302
   PubMed Web of Science ®Google Scholar
• Romero R, Gotsch F, Pineles B, Kusanovic JP. Inflammation in pregnancy: its roles in reproductive physiology, obstetrical complications, and fetal injury. Nutr Rev 2007;65:S194–02
   PubMed Web of Science ®Google Scholar
• Hassan SS, Romero R, Haddad R, et al. The transcriptome of the uterine cervix before and after spontaneous term parturition. Am J Obstet Gynecol 2006;195:778–86
   PubMed Web of Science ®Google Scholar
• Haddad R, Gould BR, Romero R, et al. Uterine transcriptomes of bacteria-induced and ovariectomy-induced preterm labor in mice are characterized by differential expression of arachidonate metabolism genes. Am J Obstet Gynecol 2006;195:822–8
   PubMedGoogle Scholar
• Rabinovitch O, Zemer D, Kukia E, et al. Colchicine treatment in conception and pregnancy: 231 pregnancies with familial Mediterranean fever. Am J Reprod Immunol 1992;28:245–6
   PubMed Web of Science ®Google Scholar
• Ferreira NR, Buoniconti A. Trisomy after colchicine therapy. Lancet 1968;2:1304
   Google Scholar
• Mijatovic V, Hompes PG, Wouters MG. Familial Mediterranean fever and its implications for fertility and pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;108:171–6
   PubMed Web of Science ®Google Scholar
• Cabili S, Livneh A, Zemer D, et al. The effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. Am J Reprod Immunol 1992;28:243–4
   Google Scholar
• Livneh A, Cabili S, Zemer D, et al. Effect of pregnancy on renal function in amyloidosis of familial Mediterranean fever. J Rheumatol 1993;20:1519–23
   PubMed Web of Science ®Google Scholar